Skip to main navigation Skip to search Skip to main content

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

  • J. R. Currier*
  • , M. De Souza
  • , S. Ratto-Kim
  • , R. Paris
  • , V. Nguay
  • , J. Cox
  • , P. Earl
  • , B. Moss
  • , S. Sriplienchan
  • , P. Thongcharoen
  • , J. Kim
  • , M. Robb
  • , N. Michael
  • , M. Marovich
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Article number1742
Pages (from-to)O27
JournalRetrovirology
Volume6
Issue numberSUPPL. 3
DOIs
StatePublished - 22 Oct 2009

Fingerprint

Dive into the research topics of 'OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial'. Together they form a unique fingerprint.

Cite this